Literature DB >> 21600365

Supportive care treatment guidelines: value, limitations, and opportunities.

Douglas E Peterson1, Rene-Jean Bensadoun, Rajesh V Lalla, Deborah B McGuire.   

Abstract

Evidence-based guidelines in clinical oncology practice are now prominent, with emphasis on clinical, health outcome and economic perspectives. Given the complexity of cancer management, a multidisciplinary approach is essential. Evidence-based guidelines to address supportive cancer care have merged expert opinion, systematic evaluation of clinical and research data, and meta-analyses of clinical trials. Production of supportive care guidelines by the interdisciplinary team is dependent on sufficient high-quality research studies. Once published, it is essential they be customized at institutional and national levels. Implementation in clinical practice is perhaps the greatest challenge. Optimal management occurs through integration of country-specific issues, including care access, healthcare resources, information technology, and national coordination of healthcare practices. The purpose of this article is to: (1) provide an overview of interdisciplinary cancer management using evidence-based guidelines; (2) delineate the theory and practice of guideline dissemination, utilization and outcome assessment; and (3) recommend future research strategies to maximize guidelines use in clinical practice.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21600365      PMCID: PMC4835803          DOI: 10.1053/j.seminoncol.2011.03.005

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  29 in total

Review 1.  Evidence-based guidelines for managing mucositis.

Authors:  Deborah B McGuire; Edward B Rubenstein; Douglas E Peterson
Journal:  Semin Oncol Nurs       Date:  2004-02       Impact factor: 2.315

2.  New directions in supportive care.

Authors:  Steven M Grunberg
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

Review 3.  Optimising antiemetic therapy: what are the problems and how can they be overcome?

Authors:  Matti Aapro
Journal:  Curr Med Res Opin       Date:  2005-06       Impact factor: 2.580

Review 4.  The role of basic oral care and good clinical practice principles in the management of oral mucositis.

Authors:  Deborah B McGuire; Maria Elvira P Correa; Judith Johnson; Patricia Wienandts
Journal:  Support Care Cancer       Date:  2006-04-25       Impact factor: 3.603

Review 5.  Multinational cooperation in trials and guidelines dealing with febrile neutropenia.

Authors:  R Feld
Journal:  Int J Antimicrob Agents       Date:  2000-10       Impact factor: 5.283

6.  NCCN Practice Guidelines for Cancer-Related Fatigue.

Authors:  V Mock; A Atkinson; A Barsevick; D Cella; B Cimprich; C Cleeland; J Donnelly; M A Eisenberger; C Escalante; P Hinds; P B Jacobsen; P Kaldor; S J Knight; A Peterman; B F Piper; H Rugo; P Sabbatini; C Stahl
Journal:  Oncology (Williston Park)       Date:  2000-11       Impact factor: 2.990

7.  Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009.

Authors:  Karin Jordan; Fausto Roila; Alexander Molassiotis; Ernesto Maranzano; Rebecca A Clark-Snow; Petra Feyer
Journal:  Support Care Cancer       Date:  2010-09-09       Impact factor: 3.603

8.  Updated clinical practice guidelines for the prevention and treatment of mucositis.

Authors:  Dorothy M Keefe; Mark M Schubert; Linda S Elting; Stephen T Sonis; Joel B Epstein; Judith E Raber-Durlacher; Cesar A Migliorati; Deborah B McGuire; Ronald D Hutchins; Douglas E Peterson
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

Review 9.  Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer.

Authors:  Christine Miaskowski; Bradley E Aouizerat; Marylin Dodd; Bruce Cooper
Journal:  J Natl Cancer Inst Monogr       Date:  2007

10.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

View more
  4 in total

1.  Is there a role for neurologist in an oncological home care team?

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Francesco Martella; Catia Capannolo; Alejandra Palma; Paolo Aloisi; Corrado Ficorella
Journal:  Neurol Sci       Date:  2012-01-19       Impact factor: 3.307

2.  The MASCC/ISOO mucositis guidelines: dissemination and clinical impact.

Authors:  Rajesh V Lalla; Fredrick D Ashbury
Journal:  Support Care Cancer       Date:  2013-08-14       Impact factor: 3.603

3.  Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group.

Authors:  Priya Patel; Paula D Robinson; Andrea Orsey; Jason L Freedman; Anne-Marie Langevin; Debbie Woods; Lillian Sung; L Lee Dupuis
Journal:  Pediatr Blood Cancer       Date:  2016-01-27       Impact factor: 3.167

4.  Patterns of oral and dental care education and utilization in head and neck cancer patients.

Authors:  Joel B Epstein; Derek K Smith; Dana Villines; Ira Parker; Jeff Hameroff; Brian R Hill; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2018-02-17       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.